MedTrace Logo

A Novel Oral Natural Extract for the Treatment of Senile Purpura

NCT01183910 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2011-06-08

No results posted yet for this study

Summary

A randomized, double-blind, placebo controlled study to assess the safety and effectiveness of a novel oral natural extract to improve the appearance of the skin of patients with senile purpura.

Conditions

  • PURPURA

Interventions

DIETARY_SUPPLEMENT

Citrus Bioflavanoid Blend

Pill Taken Twice a Day

DIETARY_SUPPLEMENT

Calcium Carbonate

Oral Tablet Taken Twice a Day

Sponsors & Collaborators

  • Nexgen Dermatologics, Inc.

    lead INDUSTRY

Principal Investigators

  • JOSHUA M BERLIN, MD · STUDY PROTOCOL, INC

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2011-07-31
Completion
2011-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01183910 on ClinicalTrials.gov